Four abstracts at SITC 2024 feature TIMING data

Applications of TIMING data include screening donors, enhancing ADCC, quantifying potency/viability, and more

EVENT ALERT

HOUSTON, Texas — November 4, 2024. CellChorus®, the dynamic single-cell analysis company™, today announced that four abstracts have been accepted for presentation at the Society for Immunotherapy of Cancer (SITC) Annual Meeting featuring data from the CellChorus Time-lapse Imaging Microscopy in Nanowell Grids™ (TIMING™) platform.

SITC is a member-driven organization specifically dedicated to improving cancer patient outcomes by advancing the science and application of cancer immunotherapy. SITC 2024 will be held November 6th to 10th at the George R. Brown Convention Center in Houston. The abstracts will be published in the Journal for ImmunoTherapy of Cancer (JITC).

The four accepted abstracts featuring TIMING data are:

Artificial Intelligence-Based Dynamic Single-Cell Imaging Reveals Enhanced Migration and Immune Synapse Formation by IDP-023, an Allogeneic g-NK Cell Product

  • Presented by Matthew Collinson-Pautz, PhD, Director of Preclinical and Translational Research at Indapta Therapeutics

  • Authors: Matthew Collinson-Pautz, Hannah Wilson, Mohsen Fathi, Lyle Babcock, Lynna Nguyen, Chris Gracia, Austin Bigley, Rebecca Berdeaux, Stefanie Mandl-Cashman

  • Friday, Nov. 8

  • Link: Abstract 365

Single-cell functional analysis accelerates design, translational research, clinical development, and process development of immunotherapies

  • Presented by Rebecca Berdeaux, PhD, Chief Scientific Officer of CellChorus

  • Authors: Hannah Wilson, Shyam Reddy Kotha, Laurence Cooper, Navin Varadarajan, Daniel Meyer, Rebecca Berdeaux

  • Friday, Nov. 8

  • Link: Abstract 1088

Single-cell proliferation assay enables rapid and quantitative donor screening

  • Presented by Hannah Wilson, PhD, Senior Scientist and Head of Microscopy at CellChorus

  • Authors: Hannah Wilson, Mohsen Fathi, Shyam Reddy Kotha, Eddie Kim, Lynna Nguyen, Laurence Cooper, Navin Varadarajan, Daniel Meyer, Rebecca Berdeaux

  • Saturday, Nov. 9

  • Link: Abstract 139

TIMING™-based functional single cell analysis reveals enhanced function of CAR T cells engineered using microfluidic vortex shedding

  • Presented by Rebecca Berdeaux, PhD, Chief Scientific Officer of CellChorus and featuring research conducted by Indee Labs

  • Authors: Brandon Sytsma, Vincent Allain, Struan Bourke, Rebecca Berdeaux, Mohsen Fathi, Jared Brewer, Leah Wilson, Justin Eyquem, Ryan Pawell

  • Friday, Nov. 8

  • Link: Abstract 241

To schedule a meeting with the CellChorus team, contact us at TIMING@cellchorus.com or book a meeting in the conference app:

About CellChorus

CellChorus® is the leader in applying artificial intelligence to quantify the function and performance of cells over time to improve the development and delivery of novel therapies that improve patient care. The company applies Time-lapse Imaging Microscopy In Nanowell Grids™ (TIMING™) with neural network-based detection to identify how multiple types of cells move, activate, kill, proliferate, and survive at single-cell resolution. The patent-protected platform links TIMING data with other single-cell modalities to provide a comprehensive understanding of cellular function and therapeutic potential. Please visit cellchorus.com for more information.

Company Contact:
Daniel Meyer
Chief Executive Officer
CellChorus Inc.
TIMING@cellchorus.com

SOURCE CellChorus Inc.